Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.
Financial Results:
Dr Lal Pathlabs Ltd reported Revenues for Q3FY24 of ₹539.00 Crores up from ₹489.00 Crore year on year, a rise of 10.22%.
Total Expenses for Q3FY24 of ₹441.00 Crores up from ₹423.00 Crores year on year, a rise of 4.26%.
Consolidated Net Profit of ₹82.00 Crores up 51.85% from ₹54.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.74, up 53.87% from ₹6.33 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.